But Christ has indeed been raised from the dead, the firstfruits of those who have fallen asleep. - 1 Corinthians 15:20

Beginning of Life

Featured Article:
RU486 Timeline


1980

  • First developed in France by pharmaceutical maker Roussel Uclaf.

September 1988

  • Approved for use in France.

June 9, 1989

  • FDA, citing safety concerns, places import alert on RU486.

January 22, 1993

  • On his third day in office, Clinton signs executive order directing HHS and FDA to expedite testing, licensing, and marketing of RU486 in U.S.

May 1, 1994

  • After months of U.S. government-brokered negotiations, Roussel Uclaf "donates" U.S. patent to Population Council of New York.

October 27, 1994

  • Population Council announces beginning of U.S. trial of RU486 involving 2,100 women.

Labor Day, 1995

  • U.S. trial of RU486 ends.

March 18, 1996

  • Population Council files marketing application with the FDA.

July 19, 1996

  • Stacked FDA advisory panel declares RU486/PG method "safe," "effective," recommends approval.

September 18, 1996

  • FDA issues letter declaring RU486 "approvable," yet withholds final approval pending the resolution of certain "manufacturing" and "labeling" issues.

October 31, 1996

  • Lawsuits by would-be investors expose that the Population Council had selected a man to handle financing for RU486 project who had been convicted of forgery in a fraudulent real estate scheme.

February 12, 1997

  • Population Council settles suit, removes forger from day-to-day operations on RU486 project.

February 28, 1997

  • Hungarian manufacturer lined up to produce RU486 backs out of deal. RU486 project delayed indefinitely while search for new manufacturer begins.

April 8, 1997

  • Roussel Uclaf announces release of remaining RU486 rights to Exelgyn, a new company headed by former Roussel Uclaf chief executive Edouard Sakiz.

April 30, 1998

  • Results from U.S. clinical trial published in the New England Journal of Medicine.

Jan/Feb 1999

  • Stories begin to appear that the Population Council and its for-profit marketing company, Danco Laboratories, have found a manufacturer and expect approval by year's end.

February 2000

  • Instead of approval, the FDA issues a second "approvable" letter, indicating it still has unresolved issues with the drug.

June 2000

  • Pro-abortion groups complain that the FDA is considering regulations to limit prescription of RU486.

September 28, 2000

  • FDA announces approval of RU486, drops or modifies many of the safeguards proposed in June.

CLR NOTE (July 2014): In November 2004, the FDA announced that “black box” labeling changes in the packaging of the abortion drug mifepristone (which was then named RU-486) would begin. Danco Laboratories produces mifepristone under its trade name Mifeprex. These revised warnings, the highest level issued by the FDA, indicate the risks such as serious bacterial infections, sepsis, and bleeding and death. As of 2011, the drug is implicated in the deaths of 14 women; 8 of those deaths were associated with sepsis.


More Beginning of Life Articles



RU486 Timeline
1980 First developed in France by pharmaceutical maker Roussel Uclaf. September 1988 Approved for use in France. June 9, 1989 FDA, citing safety concerns, places import alert on RU486....
July 25th, 2014
CLR Position Statements on Abortion and Euthanasia
Christian Life Resources' Position Statement on Abortion: Click Here Christian Life Resources' Position Statement on Euthanasia: Click Here
June 26th, 2014
Conception Begins at Fertilization
When studying for my doctorate in Human Anatomy at the University of Iowa, I completed a course in Embryology. We were clearly taught that conception was when the maternal and paternal...
April 29th, 2014
U.S. Abortion Statistics By Year (1973-Current)
TOTAL ABORTIONS SINCE 1973: 56,662,169 Based on numbers reported by the Guttmacher Institute 1973-2008, application of CDC decline % for 2009, 2010 to last Guttmacher number with projections...
January 10th, 2014
Flint Pregnancy Counseling Center Gets a New Start
Our labor began about 15 years ago, and over the last 12 months the labor pains became more intense. There were false contractions, but on September 9, 2013, the Lord allowed us to...
November 22nd, 2013
The Holy Grail of Medicine - A Look at Ethical Stem Cell Research
No one believed him. No one thought Dr. Shinya Yamanaka had managed to do the impossible. The 44-year-old physician/scientist from Japan had been encouraged to enter medicine by his...
November 19th, 2013
Born This Way!
Adapted from Pastor Fleischmann's blog (www.RobertFleischmann.com) from August 27, 2013: It is becoming a common mantra among those who cite sexual preferences outside of the norm....
November 14th, 2013
Why Me?: Dealing with the Grief of Miscarriage or Stillbirth
Dear God, why me? There are children and babies and pregnant women all around me and now my womb is empty. Why did this have to happen to me? What went wrong? These haunting questions...
October 1st, 2013
My Son, Maxwell
My son, Maxwell, was born on April 6, 2011. He was diagnosed with Down syndrome (DS) when he was two days old. I have since learned that Down syndrome, also known as trisomy 21, is...
June 12th, 2013
The Journey of Forgiveness - A Look at the Abortion Decision
Roe v. Wade seemed like a timely solution to a very big problem in young women’s lives, namely an unwanted pregnancy. What would one “do” with an unplanned baby?...
June 12th, 2013


Things to Consider

Statement on ALS and the Ice Bucket Challenge

On his blog at www.robertfleischmann.com (and more specifically at http://www.robertfleischmann.com/archives/140), Christian Life Resources' National Director, Pastor Robert Fleischmann,...

more...

Would a friend, relative, or acquaintance find a particular page or article useful? Fill out the form below to send it to a friend!

 
 Your Name:    
 Your Email:    
   
 Friend's Name:    
 Friend's Email:    
 Include Note:    
 Type the 2 words:
 

Please fill out the small form below to leave a comment or suggestion about the page you were just visiting.  Any and all feedback is appreciated!  Your feedback will help make our website even better.

 
 Your Name:    
 Email:    
 Phone:    
 Feedback:    
 Type the 2 words:
 
Quantcast